Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-27 @ 11:05 AM
Study NCT ID:
NCT05727358
Status:
COMPLETED
Last Update Posted:
2023-02-14
First Post:
2023-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression
Sponsor:
PLA Rocket Force Characteristic Medical Center
Organization:
Study Overview
Official Title:
Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to discover the effectiveness of group-based Acceptance and Commitment Therapy (ACT) in treating depression for acute stroke patients. The main question\[s\] it aims to answer are:
* Group-based ACT (G-ACT) could significantly reduce the depressive symptoms in patients with acute stroke,
* the interventional efficacy could be maintained at 3-month follow-up
* similar benefits would be observed for quality of life (QOL), sleep quality, psychological flexibility, cognitive fusion, and confidence.
The patients included to the control group received usual care support in hospital, and the patients included to the intervention group received G-ACT and usual care support. the G-ACT treatment in this study comprised 7 sessions of 45-60 minutes and was administered throughout the course of the 4-week long trial.
* Group-based ACT (G-ACT) could significantly reduce the depressive symptoms in patients with acute stroke,
* the interventional efficacy could be maintained at 3-month follow-up
* similar benefits would be observed for quality of life (QOL), sleep quality, psychological flexibility, cognitive fusion, and confidence.
The patients included to the control group received usual care support in hospital, and the patients included to the intervention group received G-ACT and usual care support. the G-ACT treatment in this study comprised 7 sessions of 45-60 minutes and was administered throughout the course of the 4-week long trial.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: